Nadia, India

Susanta Hazra

This inventor holds 1 USPTO granted patent. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susanta Hazra. Retrieved from https://idiyas.com/inventor/susanta-hazra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Susanta Hazra

Introduction

Susanta Hazra is a notable inventor based in Nadia, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new forms of existing medications. His work focuses on improving the bioavailability and effectiveness of therapeutic agents.

Latest Patents

One of his key inventions is related to Metaxalone polymorphs. This patent provides two crystalline forms, A and B, of the skeletal muscle relaxant and anxiolytic agent, Metaxalone. The invention outlines a process for the preparation of these forms, which are bioavailable. Furthermore, it includes pharmaceutical compositions that utilize these crystalline forms, aimed at relieving discomfort associated with acute, painful musculoskeletal conditions. Susanta Hazra holds 1 patent for this innovative work.

Career Highlights

Susanta Hazra is currently employed at Fresenius Kabi Oncology Limited, where he continues to contribute to advancements in pharmaceutical research and development. His expertise in the field has positioned him as a valuable asset to his organization.

Collaborations

Throughout his career, Susanta has collaborated with several professionals, including Subrata Sarkar and Jyan Shankar Mahanty. These collaborations have fostered a productive environment for innovation and development in their respective projects.

Conclusion

Susanta Hazra's contributions to the field of pharmaceuticals, particularly through his patent on Metaxalone polymorphs, highlight his commitment to improving patient care. His work exemplifies the impact of innovation in the medical field, paving the way for more effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…